Birdwatch Note
2022-02-01 07:47:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Kowa Co. of Japan stated the drug is still in Phase III trials being tested on a large group of humans. Side effects, dangers and overall effectiveness is still not known, as this is preliminary data only. The drug is not approved for use in Japan and the US. https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/
Written by 9795BF8962792425EFA8D2F4F92685B4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1488318417752838145
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1488418682271375363
- noteId - 1488418682271375363
- participantId - 9795BF8962792425EFA8D2F4F92685B4
- noteAuthorParticipantId -
- createdAtMillis - 1643701641992
- tweetId - 1488318417752838145
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Kowa Co. of Japan stated the drug is still in Phase III trials being tested on a large group of humans. Side effects, dangers and overall effectiveness is still not known, as this is preliminary data only. The drug is not approved for use in Japan and the US. https://www.reuters.com/business/healthcare-pharmaceuticals/japans-kowa-says-ivermectin-effective-against-omicron-phase-iii-trial-2022-01-31/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-02-01 07:47:21 UTC (1643701641992) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | |||
| 2022-02-01 07:47:21 UTC (1643701641992) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
9795BF8962792425EFA8D2F4F92685B4 |
Note Ratings
| rated at | rated by | |
| 2022-02-01 07:15:42 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-02-01 07:15:42 -0600 | Rating Details |